Anbio Biotechnology Files Amended 20-F Annual Report
Ticker: NNNN · Form: 20-F/A · Filed: 2026-04-09T06:04:15-04:00
Sentiment: neutral
Topics: amended-filing, annual-report, biotechnology, financials
TL;DR
Anbio Biotech just dropped an amended 20-F for 2025, check the XBRL for deets.
AI Summary
Anbio Biotechnology filed an amended annual report (20-F/A) for the period ending December 31, 2025. The filing, accepted on April 9, 2026, includes various XBRL documents detailing financial information. The company's principal executive offices are located in Frankfurt am Main, Germany.
Why It Matters
This amended filing provides updated financial and operational details for Anbio Biotechnology, crucial for investors and stakeholders to assess the company's performance and outlook.
Risk Assessment
Risk Level: medium — As an amended annual report, it may contain significant updates or corrections to previously disclosed information, requiring careful review by investors.
Key Numbers
- 2025-12-31 — Fiscal Year End (The period covered by the annual report.)
- 2026-04-09 — Filing Date (Date the amended 20-F/A was accepted by the SEC.)
Key Players & Entities
- Anbio Biotechnology (company) — Filer of the 20-F/A
- 0001982708 (company) — CIK number for Anbio Biotechnology
- 2026-04-09 (date) — Filing date of the amended 20-F/A
- 2025-12-31 (date) — Period of report for the 20-F/A
- FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308 (location) — Mailing and Business Address
FAQ
What is the primary purpose of this 20-F/A filing?
This is an amended annual report (20-F/A) for Anbio Biotechnology, covering the period ending December 31, 2025, filed and accepted on April 9, 2026.
Where is Anbio Biotechnology's principal place of business?
Anbio Biotechnology's business address is listed as FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308.
What is the CIK number associated with Anbio Biotechnology?
The CIK number for Anbio Biotechnology is 0001982708.
What type of financial filing is this?
This is a Form 20-F/A, which is an amended annual and transition report of foreign private issuers.
What is the SIC code for Anbio Biotechnology?
The SIC code for Anbio Biotechnology is 2835, which pertains to In Vitro & In Vivo Diagnostic Substances.
From the Filing
EDGAR Filing Documents for 0001185185-26-001313 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend] SEC Accession No. 0001185185-26-001313 Filing Date 2026-04-09 Accepted 2026-04-09 06:04:15 Documents 12 Period of Report 2025-12-31 Interactive Data Document Format Files Seq Description Document Type Size 1 FORM 20-F/A1 anbio20fa1123125.htm iXBRL 20-F/A 49873 Complete submission text file 0001185185-26-001313.txt 274842 Data Files Seq Description Document Type Size 2 XBRL SCHEMA FILE nnnn-20251231.xsd EX-101.SCH 3314 3 XBRL DEFINITION FILE nnnn-20251231_def.xml EX-101.DEF 19790 4 XBRL LABEL FILE nnnn-20251231_lab.xml EX-101.LAB 38269 5 XBRL PRESENTATION FILE nnnn-20251231_pre.xml EX-101.PRE 20180 15 EXTRACTED XBRL INSTANCE DOCUMENT anbio20fa1123125_htm.xml XML 7679 Mailing Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308 Business Address FRIEDRICH-EBERT-ANLAGE 49 FRANKFURT AM MAIN 2M 60308 4916096247281 Anbio Biotechnology (Filer) CIK : 0001982708 (see all company filings) EIN. : 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231 Type: 20-F/A | Act: 34 | File No.: 001-42526 | Film No.: 26849720 SIC : 2835 In Vitro & In Vivo Diagnostic Substances (CF Office: 03 Life Sciences)